PRAME was comprehensively expressed in MBM (median: 79.8%, range: 119.4–72.8%) with one exception (Pat10) that showed no PRAME expression and was classified as primary central nervous system (CNS) melanoma. This evidence concerns the gene PRAME and melanoma.